Found 1299 clinical trials
Barostim Therapy for Heart Failure
This trial studies the safety and effectiveness of Baroreflex Activation Therapy® in volunteers with Heart Failure despite treatment. Volunteers are randomized to receive Barostim Neo®
- 118 views
- 13 Aug, 2019
- 1 location
Lux Trends: LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study
The primary objective of this study is to collect physiological measurement data and heart failure (HF) event data that will be used to design and develop new diagnostic features for the
- 0 views
- 29 Nov, 2022
- 1 location
AIM POWER: Artificial Intelligence Mobile Health Trial of a Digital Platform to Optimize Guideline Directed Heart Failure Therapy Using Wearable Sensors
Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) subjects.
- 0 views
- 29 Nov, 2022
- 1 location
B3461087 - Tafamidis
heart failure with preserved ejection fraction (HFpEF)].
- 0 views
- 09 Jun, 2022
- 5 locations
Are you undergoing treatment for Congestive Heart Failure?
Are you undergoing treatment for Congestive Heart Failure?
- 682 views
- 08 Nov, 2020
- 1 location
Chronic Heart Failure – Ages 18-85
Chronic Heart Failure – Ages 18-85
- 170 views
- 25 Mar, 2021
- 1 location
Patients with Heart Failure and currently on a loop diuretic
gathered during this clinical trial may support further drug development, including larger trials in patients with heart failure. The study drug is being developed with the intention of treating
- 96 views
- 23 Nov, 2020
- 1 location
Study for patients with stable heart failure of ischemic origin
We are carrying out a clinical trial with an investigational drug that is being developed with the intention of treating patients with heart failure of ischemic origin (heart failure characterised
- 99 views
- 23 Nov, 2020
- 1 location
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)
- 274 views
- 25 Mar, 2021
- 1 location